YC Companies/Summer 2021/Mindstate Design Labs
Mindstate Design Labs logo

Mindstate Design Labs

Clinical-stage AI neuroengineering platform

Summer 2021Healthcare / Healthcare -> Drug Discovery and DeliverySan Francisco, CA, USA7 employees
Machine Learning
Mental Health Tech
Biotech
Therapeutics
AI

About

We're making every therapeutically valuable emotion available on demand in pharmaceutical form. Our Osmanthus platform is an ensemble of AI models that synthesize the world’s largest datasets of psychoactive pharmacology and phenomenology, quantitatively pinpointing the combination of neurotransmitter receptor activity that underlies various emotional as well as cognitive and perceptual states. Our lead program MSD-001 is designed to be rapid-acting and produce heightened emotional and cognitive flexibility without hallucinations. MSD-001 is currently in human trials, and will be the base ingredient for multiple drug combination "emotions in a bottle" such as empathy, awe, clarity, or beauty.

Founders (2)

Dillan DiNardo
Founder/CEO
Tom Ray
Founder

Details

Status
Active
Stage
Early
Team Size
7
Regions
United States of America, America / Canada, Remote, Partly Remote